Search filters

List of works by Tahereh Taheri

A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers.

scientific article

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

scientific article

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy

scientific article published on 25 March 2016

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites

scientific article published on 14 July 2017

Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis.

scientific article published on 21 July 2017

DNA Integration in Leishmania Genome: An Application for Vaccine Development and Drug Screening

scientific article published in January 2016

Drug Targeting to Macrophages With Solid Lipid Nanoparticles Harboring Paromomycin: an In Vitro Evaluation Against L. major and L. tropica.

scientific article published on 9 November 2015

EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice.

scientific article published on 19 December 2015

Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae

scientific article published on 26 March 2011

Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model

scientific article published on 23 May 2016

Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen

scientific article (publication date: March 2014)

Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96.

scientific article

Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis

scientific article published in March 2003

Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies

scientific article published on 25 December 2010

Generation of stable L. major(+EGFP-LUC) and simultaneous comparison between EGFP and luciferase sensitivity

scientific article published on 28 January 2015

Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population

scientific article published in January 2004

Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.

scientific article published in May 2004

Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine

scientific article

In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite.

scientific article

Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice

scientific article published on 03 January 2020

Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice

scientific article

Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients

scientific article

Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivity

scientific article published on 22 April 2010

Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model

scientific article published on 19 August 2015

Leishmania-based expression systems.

scientific article

Live vaccination tactics: possible approaches for controlling visceral leishmaniasis

scientific article

PUF Proteins: Cellular Functions and Potential Applications.

scientific article published on 14 September 2016

Post-Genomics and Vaccine Improvement for Leishmania

scientific article

Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.

scientific article published in May 2005

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.

scientific article published on November 2012

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

scientific article published on 8 October 2009

Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation

scientific article

Retracted: Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis

retracted article

Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.

scientific article

The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica

scientific article published on 07 January 2020

Type I signal peptidase from Leishmania is a target of the immune response in human cutaneous and visceral leishmaniasis

scientific article published on May 2004

Paulina is supported by:

About Paulina

Help